Skip to main content
Log in

Asthma-COPD-Overlap-Syndrom

Studie spricht gegen Nutzen durch inhalative Kortikosteroide

  • journal club
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Global Initiative for Asthma (GINA) Guidelines (2014) Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). www.ginasthma.org

  2. Menezes AM, Montes de Oca M, Peréz-Padilla R et al. Chest 2014;145: 297–304.

    Article  PubMed  Google Scholar 

  3. Hardin M, Cho M, Merry-Lynn McDonald M-L et al. Eur Respir J 2014;44: 341–50.

    Article  CAS  PubMed  Google Scholar 

  4. Celli BR, MacNee W, Force AET. Eur Respir J. 2004;23:932–46.

    Article  CAS  PubMed  Google Scholar 

Literatur

  • Lim HS, Choi SM, Lee J et al. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Ann Allergy Asthma Immunol 2014;113(6):652–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Kohlhäufl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kohlhäufl, M. Studie spricht gegen Nutzen durch inhalative Kortikosteroide. Pneumo News 7, 32 (2015). https://doi.org/10.1007/s15033-015-0144-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-015-0144-5

Navigation